Abstract
Background and aims
Diabetes is one of the causes of end-stage renal disease, so that about 70% of all diabetic patients have nephropathy [1] . Diabetic nephropathy is one of the most important factors determining the severity of diabetes.
Physiopathology of diabetes is complex and not fully identified. Evidence shows that endocrine system is altered in diabetes. Previous studies show that the overall performance of the endocrine system including hypothalamus, pituitary, thyroid, adrenal, and parathyroid and adipose tissue hormones impaired [2] . Prolactin (PRL) is a protein hormone that plays important role in the production of milk. PRL is not only important for lactation, but also involved in reproduction, growth and development, and plays a role in the regulation of osmolality and metabolism [3] . Many studies have been done about changes in PRL levels in diabetes but the results are somewhat contradictory. Induced diabetes in rats after delivery reduces the secretion of PRL followed by decreased milk production [4] and also reduces the secretion of PRL in response to breastfeeding [5] . Human studies have shown that in men with type one and two diabetes, PRL levels are normal [6] or increased [7] whereas the level is decreased in women with type one diabetes (T1DM) [8] . In some previous studies, there have not been differences between serum PRL levels in type one and two diabetes [7, 9] Altogether the interaction between diabetes and PRL, and the effect of renal failure in diabetic patients on PRL levels have not been understood properly. In this study, the relationship between changes in serum PRL levels in diabetic patients with renal failure has been evaluated.
Material and Methods

Study population:
This study was approved by the Ethics Committee of the Urmia university of medical sciences. In this study, 223 individuals from Mahabad city of west Azarbayjan province, a region in northwest Iran, were enrolled; after assessment of inclusion/ exclusion criteria 189 individuals were evaluated (66 men and 123 women, aged 19-87). Of the 223 baseline participants, we excluded participants due to: PRL not measured (n=15), pregnancy (n=4), hormone therapy (n=2), thyroid and liver disorders (n=6) and missing data (n=7).
After collecting precise information on medical history, female menstruation status, hormone replacement therapy (HRT), age and sex, in the final study sample of 189 individuals were divided to three groups: Control group (C), Diabetic group (D) and Diabetic Nephropathy group (DN). More information of the subjects in each of the groups is illustrated in Table 1 . The concentrations of plasma urea and creatinine were measured using autoanalyzer (Selectra-XL, Netherland). Serum sodium and potassium were assessed by flame photometer (Corning 480). Serum glucose concentration was determined using the kit and autoanalyzer (Selectra-XL). HbA1c was determined by assay kit and the method of automated highperformance liquid chromatography analyzer chromatography (Eppendorf ECOM 6125, Germany).
Serum PRL Measurement:
Blood samples were drawn from the cubital vein between 8.00 a.m. and 12:00 a.m. and centrifuged at 3000 g at 5 ˚C for 10 min to separate sera then stored at 20 C until biochemical analysis. Serum PRL was determined from frozen sera of participants using chemiluminescent Immunoassay on an ELISA reader (Anthos 2020). Serum control was used for low, normal and high hormone level (Monobind, USA, Lot: MCA1A2, MCB1A2 and MCC1A2, respectively). For determination the deviation of the results before and after serum storage and for stability verification of PRL measurement, we randomly selected and measured PRL concentrations in fresh serum samples of some male and equal number of female participants after serum extraction. We retested PRL concentrations in the same samples. The laboratory reference range of PRL was 3.31-19.80 ng/mL for adult men and 5.4-24.2 ng/mL for adult women.
Statistical analysis
Distribution of data was checked by Kolmogorov-Smirnov test. Since distribution of data was normal, parametric test was used to analyze the data. Group differences were compared using a one-way analysis of variance followed by Tukey's test to determine differences between groups.
Results were expressed as the mean ± S.E. of the mean. Differences were considered statistically significant at p<0.05. Table 2 shows the results of serum Sodium, Potassium, Urea and Creatinine. Sodium was significantly increased in diabetic nephropathy (DN) group compared with control subjects (p˂0.001). There was no significant difference on sodium level between diabetic (D) and control(C) group. Potassium was significantly increased in diabetic nephropathy (DN) group compared with control and diabetic groups (p˂0.001), and there was significant difference on potassium level between diabetic and control group (p˂0.001). Urea level was non-significantly higher in diabetic group compared with control subjects. Also, urea was significantly higher in diabetic nephropathy (DN) group compared with control and diabetic groups (p˂0.001). The changes of creatinine in study groups were similar to urea changes. In diabetic nephropathy (DN) group creatinine was increased significantly in comparison with control and diabetic groups (p˂0.001).
Results
The results of blood glucose, hemoglobin A1c and PRL are presented in Table 3 . Blood glucose level in diabetic (D) and diabetic nephropathy (DN) groups was significantly higher than that of control (C) group (p˂0.001). Changes in hemoglobin A1c (HbA1c) in any groups was similar and in line with changes in glucose. Evaluating the results of serum PRL levels showed that PRL was significantly lower in diabetic (D) group compared with control and diabetic nephropathy groups (p˂0.001). Elevation of PRL level in diabetic nephropathy (DN) was significant compared with control and diabetic groups (p=0.036 and p˂0.001 respectively, Figure 1 & Table 4 ). In healthy control group, serum PRL concentrations in females were higher than those of males (Table 4) .
Discussions
The overall results of present study showed that serum sodium, potassium, urea, creatinine, blood glucose, hemoglobin A1c and PRL were significantly increased in diabetic Nephropathy (DN) patient. Also, the results show significant decrease in serum PRL level in diabetic patient.
As mentioned before altogether the interaction between diabetes and PRL, and the effect of renal failure in diabetic patients on PRL levels have not been understood properly. In this study, the changes in serum PRL levels in people with diabetes and diabetic nephropathy were assessed. As expected, blood glucose levels, glycosylated hemoglobin and potassium were significantly higher in diabetic patients than the control group. In the diabetic group compared with the healthy control group and diabetic nephropathy serum PRL significantly reduced. This study confirms the results of previous studies that have suggested plasma PRL decreases in early diabetes [4, 8] . The decline may be due to pituitary damage and destruction of lactotroph cells in early stages of diabetes [20] . Tiange Wang et al have reported that a high circulating PRL level was significantly associated with a lower risk of prevalent diabetes in men and postmenopausal women [21] . With the assumption that PRL levels in normal subjects are influenced by sex, previous studies and literature suggest that the average blood PRL levels in females are slightly higher than males [22, 23] . In this study, we also observed that a PRL level in healthy females was higher than healthy males. In current study, serum PRL level in patients with diabetic nephropathy was significantly increased compared with diabetic patients; this finding is a little more complicated.
In this study, we observed that blood levels of urea, creatinine, potassium and sodium in patients with diabetic nephropathy was significantly higher than those in people with diabetes and these findings suggest kidney damage in individuals. Another finding that the mean age of patients with diabetic nephropathy was higher than that of diabetic patients without nephropathy suggesting that diabetes has led to nephropathy over the time. Assessment of changes in PRL levels in patients with diabetic neuropathy was the main objective of this study and the results showed a significant increase of serum PRL levels in diabetic nephropathy compared with diabetic patients without nephropathy. The main finding of this study is that it increases blood PRL levels in diabetic patients with nephropathy. According to the influence of sex on PRL levels, PRL is normally higher in healthy female subjects. Despite the twice as much the number of females than males in diabetic group, a significant decrease in serum PRL was seen in this study, in turn, represents the lack of influence of individual's gender and confirms that diabetes itself was PRL-lowering condition. Moreover, in the diabetic nephropathy group the number of females was far less than males. So, high PRL levels in this group can not only be affected by sex, but PRL has been increased due to severe kidney damage or may be another factor. Our results are similar to the results of previous study that reported Cirrhosis and chronic renal failure cause hyperprolactinemia [24] . These abnormalities may be inducing an increased level of PRL secretion and a decreased metabolic clearance rate [25] . PRL is normally metabolized in the kidneys and liver; and in case of diabetic nephropathy, it is likely that excessive accumulation of PRL in the blood cannot be discharged effectively and consequently leads to buildup of PRL in the blood.
Conclusions
The results of present study showed that serum PRL levels increases in diabetic patients with nephropathy. A probable mechanism can be either over production of PRL from its natural sources or low clearance of it in diabetesinduced damaged kidneys. Further detailed studies should be conducted to evaluate the precise mechanisms of increase of PRL in these patients.
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